BUREAU OF VETERINARY DRUGS (BVD) - HEALTH CANADA: CAHI HAS LOBBIED FOR CHANGE TO THE REGULATORY PROCESS FOR APPROVAL OF NEW ANIMAL PHARMACEUTICAL PRODUCTS. WE MAY ALSO MEET WITH TREASURY BOARD ON THIS ISSUE.NON-APPROVED ANIMAL HEALTH PRODUCTS: ACTIVELY PURSUING THE ESTABLISHMENT OF A COMPLIANCE AND SURVEILLANCE PROGRAM FOR ANIMAL PHARMACEUTICALS. CAHI HAS HAD INTERVENTION WITH POLITICIANS, POLITICAL ASSISTANTS AND/OR BUREAUCRATS WITH THE FEDERAL DEPARTMENTS OF AGRICULTURE, HEALTH, TREASURY BOARD AND TRADE.GOOD MANUFACTURING PRACTICES (GMPS): DEVELOPMENT OF VETERINARY DRUG ANNEX TO THE GMP REGULATIONS.ADVERTISING OF PRESCRIPTION DRUGS FOR ANIMAL USE: CAHI HAS PROPOSED RECOMMENDATIONS TO CHANGE THE EXISTING ADVERTISING REGULATIONS UPON REQUEST BY BVD FOR STAKEHOLDER REVIEW AND INPUT.
Objets poursuivis : Renseignements prospectifs :
WE WILL CONTINUE TO LOBBY ON THE SAME ISSUES NOTED ABOVE.